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Evidence for Rho protein regulation of renal tubular epithelial active (GTP-bound) and inactive (GDP-bound) forms,
cell function. thereby functioning as molecular switches [1–3]. While
Background. Rho proteins are small guanine 59-triphosphate the Rho family consists of at least seven distinct proteins,(GTP)-binding proteins felt to be important regulators of several
most information is available with regard to Rho (A, Baspects of cell function, including the organization of the actin
and isoforms), Rac (1 and 2 isoforms), and Cdc 42 (Cdccytoskeleton. The effects of Rho proteins on the regulation of
renal tubular epithelial cell function are not known. 42Hs and G25K isoforms). Substantial data suggest that
Methods. Selected bacterial toxins that inhibit Rho protein these Rho proteins regulate various aspects of the actin
function were used to examine the effect of Rho in cultured cytoskeleton [1–3]. For example, activation of Rho leadsrenal tubular epithelial cells.
to the assembly of actin-myosin stress fiber filaments.Results. Clostridium difficile toxin A significantly and dose
dependently inhibited LLC-PK1 cell 3H-thymidine uptake and Activation of Rac produces an assembly of a network
healing of small wounds made in confluent monolayers, and it of peripheral cellular actin filaments, and activation of
induced apoptosis. A second Clostridium difficile toxin (toxin B) Cdc 42 induces the formation of actin-rich cell protru-
that acted via a different receptor also impaired LLC-PK1 thy- sions [1–3]. These Rho proteins also appear to be in-midine uptake and wound healing, and it induced apoptosis.
volved in focal adhesion complex formation and to par-A third bacterial toxin, C3 toxin from Clostridium botulinum,
also impaired LLC-PK1 thymidine uptake and stimulated apo- ticipate in gene transcription [1–3]. Collectively, Rho,
ptosis in LLC-PK1 cells. Since Rho inhibition disrupted organi- Rac, and Cdc 42 have been implicated in the regulation
zation of the actin cytoskeleton, we examined the effects of of cell shape, movement, polarity, and progression ofanother agent that disrupted the actin cytoskeleton (cytocha-
the cell cycle.lasin D) and found significant dose-dependent effects that im-
Despite substantial information demonstrating the im-paired LLC-PK1 thymidine uptake and wound healing and that
induced apoptosis. The effects of toxin A and cytochalasin D portance of Rho proteins as key cellular regulators, there
to induce apoptosis were not associated with significant changes is limited information on Rho protein modulation of renal
in expression of Bcl-2, BAD, or BAK proteins and were sig-
cell function. Some indirect evidence, however, suggestsnificantly attenuated by a pancaspase inhibitor.
that Rho proteins are important with regard to selectedConclusions. Our results suggest that Rho proteins are im-
portant endogenous regulators of several aspects of renal tubu- aspects of renal tubular and mesangial cell function.
lar epithelial cell function, including proliferation, migration, Thus, exposure of renal epithelial and mesangial cells to
and apoptosis. Further studies are needed to clarify the cellular 3-hydroxy-3-methylglutaryl coenzyme A (HMG-CoA)mechanisms of Rho regulation of renal epithelial cell function.
reductase inhibitors attenuates proliferation, stimulates
apoptosis, and results in impairment of other aspects of
cell function [4–8]. The results from HMG-CoA reduc-
The Rho family is a member of the Ras superfamily
tase inhibition are sometimes difficult to interpret, how-of guanine 59-triphosphase (GTP)-binding proteins. Like
ever, since such inhibition not only attenuates Rho pro-other members of the Ras superfamily, these Rho family
tein activity [9], but also the activity of several otherproteins respond to external stimuli by cycling between
regulatory proteins and impairs formation of numerous
important cellular components such as ubiquinone and
cholesterol.Key words: apoptosis, kidney cells, cell proliferation, GTP-binding pro-
teins. The availability of bacterial toxins that inactivate se-
lected Rho proteins provides an opportunity to defineReceived for publication November 15, 1999
more clearly the role of Rho family members on regula-and in revised form April 17, 2000
Accepted for publication May 30, 2000 tion of renal epithelial cell function. For example, Clos-
tridium botulinum C3 ADP-ribosyl transferase toxinÓ 2000 by the International Society of Nephrology
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Fig. 1. Effect of Clostridium difficile toxin A on 3H-thymidine uptake Fig. 2. Effect of Clostridium difficile toxins A and B for 24 hours
(A) and migration, as assessed by rate of healing of small wounds on LLC-PK1 apoptosis, as assessed by annexin V binding. Each bar
made within confluent monolayers (B) in LLC-PK1 cells. For thymidine represents the mean 6 SEM of five experiments. Values are expressed
studies, each bar represents the mean 6 SEM of four experiments done as the percentage of cells demonstrating either necrosis (annexin V and
in triplicate under each condition. Values are expressed as a percentage propidium iodide uptake, j) or apoptosis (only annexin V uptake, ).
of simultaneously studied controls. At 10 ng/mL and higher, Toxin A A significant increase in apoptosis (P , 0.05) occurred with each tested
significantly (P , 0.001) decreased 3H-thymidine incorporation. For the concentration of Toxin A. At 0.1 ng/mL, Toxin A did not increase
migration experiments, each bar represents the mean 6 SEM of four apoptosis (data not shown). At 100 ng/mL, Toxin B induced significant
experiments. Values are expressed as a percentage of simultaneously apoptosis (P , 0.025).
studied controls. Symbols are: (j) measurement at 6 hours; ( ) mea-
surement at 24 hours. Toxin A significantly (P , 0.05) decreased wound
healing at each concentration and time point studied except at six hours
for the 1.0 ng/mL dose (P 5 NS). fluid (Scintisafe Econ 2) was obtained from Fisher Sci-
ence (St. Louis, MO, USA). Culture media RPMI 1640,
penicillin, streptomycin, N-2-hydroxyethyl piperazine-
(C3) modifies Rho A, B, and C on asparagine 41, thereby N1-2-ethanesulfonic acid (HEPES), cytochalasin D, col-
inhibiting their function [10–12]. Clostridium difficile tox- chicine, lumicolchicine, and glutamine were obtained
ins A and B (Tox A and Tox B, respectively) inhibit the from Sigma Chemical (St. Louis, MO, USA). A pancas-
activity of Rho A, B, and C, Rac, and Cdc 42 by glu- pase inhibitor (boc-aspartyl [OMe]-fluoromethyl ketone)
cosylating these proteins at either threonine 37 (Rho) or was obtained from Enzyme System Products (Livermore,
35 (Rac and Cdc 42) [13, 14]. Also, a Clostridium sordelli CA, USA). Rhodamine phallotoxin was from Molecular
lethal toxin (LT82) monoglucosylates and thereby inacti- Probes (Eugene, OR, USA). Clostridium difficile tox A
vates Ras, Rac, Ral, and Rap proteins [15, 16]. The and tox B were obtained from TechLab (Blacksburg, VA,
present studies use these toxins to test the hypothesis USA). LT82 was purified as described previously [17].
that Rho proteins are important regulators of several Mouse antibodies directed against BAK, BAX, and Bcl-x
were obtained from Pharmingen (San Diego, CA, USA),aspects of LLC-PK1 renal tubular epithelial cell function.
and a mouse antibody directed against BAD was ob-
tained from Transduction Labs (Lexington, KY, USA).METHODS
Materials Cell and culture conditions
3H-thymidine (70 to 85 Ci/mmol) was obtained from LLC-PK1 cells were obtained from American Type
Tissue Collection (Bethesda, MD, USA) and were usedAmersham (Arlington Heights, IL, USA). Scintillation
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Fig. 3. Effect of C3 botulinum toxin for 24
hours on LLC-PK1 apoptosis and necrosis.
The bars represent the mean 6 SEM of four
experiments. Values are expressed as the per-
centage of cells demonstrating either necrosis
(j) or apoptosis ( ). At 1.0 mg/mL, C3 sig-
nificantly (P , 0.02) increased both necrosis
and apoptosis.
at passages 90 to 125. LLC-PK1 cells were grown in RPMI adhered overnight, and then the medium was changed to
1640 medium supplemented with 20 mmol/L HEPES, serum-free medium RPMI with 20 mmol/L HEPES for
100 mg/mL penicillin, and 6% calf bovine serum. After 20 to 24 hours. The medium was changed again with
initial seeding, LLC-PK1 cells typically reached conflu- serum-free medium. Rectangular areas of denuded cells
ence in 48 to 72 hours. were created near the center of the monolayer using
sterile needles as described previously [18, 19]. A grid
Growth activity assay of two vertical lines dissecting two horizontal lines (“tic-
Confluent monolayers of 75 cm2 flasks of LLC-PK1 tac-toe”-like) were made, and the rectangular areas were
were treated with 0.05% trypsin-0.01% ethylenediamine- measured (time 0) and labeled. The wounds were mea-
tetraacetic acid (EDTA) for four minutes at 378C. The sured with an eyepiece reticule in an inverted microscope
cells were rinsed from the flask with serum-containing with phase optics at 310 to 320 (Nikon IM 35, Tokyo,
media, centrifuged at 300 to 400 g for five minutes, resus- Japan). Compounds were added to the plates, and the
pended in 2 to 3 mL of medium, and counted on a cells were incubated at 378C. The denuded areas were
hemocytometer. LLC-PK1 cells were seeded in 24-well measured again at 6 and 24 hours after injury. Each study
plates at 2 3 104 cells/well in RPMI media with HEPES condition was compared with a simultaneously measured
and streptomycin/penicillin. The cells were allowed to control, and the percentage of surface area healed was
adhere for 24 hours. The media were then changed to calculated. An average of six to eight denuded areas
serum-free RPMI media with HEPES and streptomycin/ was measured in each experiment for both control and
penicillin, which was maintained for 48 hours prior to
treated cells and was averaged to obtain a number (N)the study. Cells were then pulsed with 0.5 mCi/well 3H-
of one for each study condition in each experiment. Thethymidine for three hours at 378C and then harvested.
individual measuring the denuded areas was unaware ofThe samples were harvested by rinsing the wells once
the treatment status of the cells. We have previouslywith phosphate-buffered saline (PBS), and cellular mate-
demonstrated that these wounded cultures heal in therial was precipitated with perchloric acid and was solubi-
absence of cellular proliferation [18].lized with 0.01N NaOH/1% sodium dodecyl sulfate
(SDS). Samples were transferred to vials. Scintillation Apoptosis analyses
cocktail was added, and the radioactivity was determined
LLC-PK1 cells were plated onto a 100 mm tissue cul-by liquid scintillation counting (Beckman Instruments,
ture plate at 105 cells/plate in RPMI medium supple-Fullerton, CA, USA).
mented with 6% calf bovine serum. The cells were then
Migration assay incubated for three days at 378C. After 72 hours, the
medium was changed to serum-free RPMI. Test agentsLLC-PK1 cells were seeded in 35 mm dishes at 7 to
10 3 105 cells/plate in serum-containing medium. The cells were then added, and the cells were incubated for 24
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hours at 378C. The cells were removed from the plates
by trypsinization and washed and stained according to
the directions included in an Apoptosis Detection Kit
(R&D Systems, Minneapolis, MN, USA). This apoptosis
detection method is based on measurement of external-
ization of phosphatidylserine to the outer leaflet of the
cell membrane by annexin V binding, which occurs dur-
ing the early stages of apoptosis. Briefly, the cells were
washed twice with PBS and then resuspended in binding
buffer. The fluorescein-conjugated annexin V reagent
and the propidium iodide reagent were added to the
cells, and the samples were incubated for 15 minutes in
the dark. The samples were analyzed by flow cytometry
following the kit guidelines with single laser emitting
excitation light at 488 nm. Cells expressing phosphatidyl-
serine on the membrane surface (early state of apoptosis)
stain positive for annexin V. The cells positive for propid-
ium iodide and annexin V were considered necrotic,
whereas the cells negative for both fluorochromes were
considered viable. A second method of detection of apo-
ptosis, based on labeling of DNA fragments that ends
with a bromolated deoxyribose triphosphate nucleotide,
was also used. Cells were incubated, exposed to test
agents, and removed from the plates, as noted previously
in this article. Subsequently, a two-color staining method
for labeling DNA breaks and total DNA, APO-BRDU
(Pharmingen) was used according to the manufacturer’s
specification with analysis by flow cytometry using a sin-
gle laser emitting excitation light at 488 nm. Fig. 4. Effect of cytochalasin D on 3H-thymidine incorporation (A)
and migration (B) in LLC-PK1 cells. In A, the bars represent the mean 6
SEM of four experiments done in triplicate and are expressed as theBcl-2 detection by flow cytometry
percentage of simultaneously studied controls. At 0.1 and 1.0 mmol/L,
This analysis was performed using a Bcl-2 Detection cytochalasin D significantly decreased LLC-PK1 3H-thymidine uptake.
In B, each bar represents the mean 6 SEM of four experiments. SymbolsKit exactly as specified by the manufacturer (Phar-
are: (j) measurements made six hours after wounding; ( ) measure-mingen). Briefly, LLCPK1 cells were plated on 60 mm ments made 24 hours after wound creation. At 0.1 and 1.0 mmol/L,
dishes in 6% calf bovine serum supplemented RPMI at cytochalasin D significantly (P , 0.01) impaired wound healing.
105 cells per plate. The cells were grown to approximately
70% confluency in three days; then the medium was
changed to serum-free RPMI, and test agents were fuged as before. The cells were resuspended in 0.5 to
added. The cells were incubated an additional 24 hours 1.0 mL PBS and analyzed by flow cytometry.
and harvested. The cells were then rinsed once with PBS
and trypsinized to remove them from the plates. The Immunoblotting assays
cells were washed once with 6% calf bovine serum/RPMI These assays were done as generally described pre-
and once with PBS by centrifugation (300 3 g) and viously [19]. To obtain cell lysates, LLC-PK1 cells were
aspiration at 48C. The cells were fixed with 4% paraform- plated in 60 mm plates at 105 cells/plate in 6% calf bovine
aldehyde in PBS for 20 minutes at room temperature. serum/RPMI, and the cells were grown to 75 to 80%
The cells were then washed twice with PBS and once confluence in three days. The medium was changed to
with 0.1% saponin/1% fetal bovine serum in PBS. The serum-free RPMI for 48 hours (total). Cells were ex-
cells were resuspended in 100 mL 0.1% saponin/1% fetal posed to test agents for 24 hours. The medium was then
bovine serum/PBS and either FITC conjugated anti–Bcl-2 removed, and the cells washed with PBS and lyzed with
antibody or an isotype-specific control antibody was 1 mL/plate 50 mmol/L Tris-HCl, pH 8.0, 140 mmol/L
added (20 mL/tube). The cells were incubated for 30 NaCl, 2.5 mmol/L EDTA, 1% Igepal CA-630 (five min-
minutes at room temperature in the dark. After 30 min- utes at 48C) and then scraped from the dishes. The lysate
utes, 1 mL/sample 0.1% saponin/1% fetal bovine serum was centrifuged at 13,000 r.p.m. at 48C and protein analy-
sis performed on the supernatant (Pierce BCA, Rock-in PBS was added to each tube, and the cells were centri-
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to 1008C for five minutes. The samples were then loaded
onto a 6% SDS polyacrylamide gel, and samples were
electrophoresed on a Bio-Rad (Hercules, CA, USA)
mini-gel system. The gel was transferred to a nitrocellu-
lose membrane. The membrane was incubated with goat
anti-mouse IgG-HRP (1/300 dilution) for one hour at
room temperature, and the proteins was detected with
enhanced chemiluminescence (ECL) Western blotting
reagents and Hyperfilm (Amersham). Bands were quan-
titated using a Sigma Gel program obtained from Jandel
Scientific Software (San Rafael, CA, USA).
Rhodamine phallotoxin staining
LLCPK1 cells were plated onto 25 mm circular glass
cover slips in a six-well plate with 5 3 104 cells in 1 mL
of serum-supplemented RPMI 1640. The medium was
changed to serum-free RPMI 1640 after three days, and
either control solutions or toxins were added. The cells
were incubated for 24 hours. The medium was aspirated,
and the cells were washed twice with warmed PBS. All
steps were preformed with the cover slips in the six-well
plates. The cells were fixed with 3.7% formaldehyde in
PBS for 10 minutes and then washed twice with PBS.
The cells were then permeabilized for three to five min-
utes with 0.1 Triton X100 in PBS and washed twice with
PBS. The cells were blocked for 20 minutes with 1% bo-
vine serum albumin/PBS at room temperature, were then
Fig. 5. Effect of cytochalasin D for 24 hours (A) and (B) colchicine stained with phallotoxin at four units per cover slip in 200
(j) and control (lumicholchine; ) on LLC-PK1 apoptosis, as deter- mL 1% bovine serum albumin/PBS for 20 minutes at room
mined by annexin V binding. The bars represent the mean 6 SEM of
temperature with samples protected from light and evapo-four experiments and express the percentage of cells with necrosis ( )
or apoptosis (j). At 1.0 and 10.0 mmol/L, cytochalasin D significantly ration. The cells were then washed three times with PBS,
(P , 0.001) increased apoptosis (A). At 1.0 and 10.0 mmol/L, colchicine and the cover slips were mounted onto slides with glyc-
slightly but significantly (P , 0.05) increased apoptosis (B). In data not
erol:PBS (1:1) solution, observed and viewed with a Zeissshown, neither colchicine nor lumicholchine significantly affected the
percentage of necrotic cells. Axloplan 2 upright microscope equipped with a Zeiss Plan
Apo 363 lens objective and reflected light fluorescence
with an Alto variable mercury illuminator.
ford, IL, USA). The samples were then diluted with PBS Statistical analyses
to the same protein concentration.
All values are expressed as the means 6 SE. StatisticalThe samples were immunoprecipitated with antibod-
analyses were done using a one-way analysis of varianceies directed against Bcl-x, BAXs, BAD, and BAK and
followed by a Scheffe’s test to determine specific differ-were incubated overnight at 48C with rocking. Prewashed
ences. P , 0.05 was considered significant.protein G-agarose (1:1 slurry; Calbiochem, La Jolla, CA,
USA) was added at 75 mL/sample, and the samples were
incubated for two hours at 48C with rocking. The samples RESULTS
were then pelleted, and the supernatant was carefully
Effects of Tox A and Tox B on LLC-PK1 cellsaspirated. The antibody-protein G-agarose complex was
These studies were done to assess the effects of Tox Asequentially washed with three buffers: Buffer 1 (10
and Tox B on LLC-PK1 cell mitogenesis (as estimated bymmol/L Tris, pH 70.2, 1.0 mol/L NaCl, 0.1% Igepal CA-
3H-thymidine uptake), migration (as assessed by wound630), Buffer 2 (10 mmol/L Tris, pH 7.2, 150 mmol/L
healing), and apoptosis (as determined by annexin VNaCl, 1.0% deoxycholate, 1.0 Triton X100, 0.1% SDS),
binding). Tox A exerted a concentration-dependent, sig-and Buffer 3 (10 mmol/L Tris, pH 7.2, 150 mmol/L NaCl,
nificant inhibition of 3H-thymidine incorporation (Fig. 1)1.0 mmol/L EDTA), and then 2 3 SDS-polyacrylamide
and stimulation of annexin V binding (Fig. 2). Tox Agel electrophoresis (SDS-PAGE) sample buffer with 5%
2-mercaptoethanol was added. The samples were heated inhibited wound healing (Fig. 1) but not in a dose-depen-
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Table 1. Effect of Clostridium difficile Toxin A and cytochalasin D
on LLC-PK1 apoptosis as assessed by Brd UTP uptake
Condition % Versus control
Toxin A ng/mL
1.0 151672 Fig. 6. Effect of Clostridium difficile toxin A and cytochalasin D on
10.0 8456188a LLC-PK1 expression of an antibody directed against Bcl-x. A represen-100.0 2,4436524a tative immunoblot is shown. Lanes 1 and 3 represent solvent controls
Cytochalasin D lmol/L for toxin A (lane 2) and cytochalasin D (lane 4). Bcl-x has two isoforms:
0.1 29633 Bcl-xL with a molecular weight of 27 kD and Bcl-xs with a molecular
1.0 1,3326250a weight of 19.5 kD. An effect of cytochalasin D to decrease expression
10.0 14,1716900a of Bcl-xL is apparent.
aP , 0.05 vs. simultaneously studied controls
healing (2 6 7%, 27 6 10%, and 225 6 15%, respec-
tively, vs. control, N 5 three paired studies, P 5 NS) ordent manner. Tox A did not induce LLC-PK1 necrosis,
as assessed by propidium iodide uptake (Fig. 2). apoptosis, as assessed by annexin V binding (control
6.1 6 4.0%; 50, 100, and 500 ng/mL; LT82, 5.9 6 3.9,Since Tox A can exert cytotoxic effects independent
of Rho inactivation [20], we studied the effects of a 6.5 6 3.2, and 12.1 6 5.6%, respectively, N 5 four studies,
P 5 NS).Clostridial difficile toxin (Tox B) that acts via a different
receptor. At 1.0 and 10.0 ng/mL, Tox B did not signifi-
Effects of Cytochalasin D on LLC-PK1 cellscantly affect either 3H-thymidine incorporation or wound
healing (data not shown). At 100.0 ng/mL, Tox B de- Since Rho protein inhibits organization of the actin
cytoskeleton, these studies were done to determine thecreased LLC-PK1 3H-thymidine incorporation by 20.1 6
10.1% versus control (N 5 four paired experiments done effects of actin cytoskeletal disruption by a Rho-indepen-
dent mechanism (cytochalasin D). The effects of cytocha-in triplicate, P , 0.05) and decreased wound healing by
56 6 4% vs. control (N 5 3 paired experiments, P , lasin D on LLC-PK1 3H-thymidine incorporation, wound
healing, and apoptosis are shown in Figures 4 and 5. As0.001). The effect of Tox B on LLC-PK1 annexin V bind-
ing and propidium iodide uptake is shown in Figure 2. can be seen, cytochalasin D exerted a significant, dose-
dependent effect to inhibit LLC-PK1 3H-thymidine up-At 100 ng/mL, Tox B was associated with an increase in
annexin V binding over control (P , 0.05). take and wound healing while stimulating apoptosis.
To determine whether the effects of Tox A and cyto-
Effects of C3 and LT82 on LLC-PK1 cells chalasin D on LLC-PK1 function occur by a similar mech-
anism, additivity experiments were carried out. In initialIn these studies, we examined the effect of a toxin
(C3), which inhibits Rho A, B, and C by a mechanism experiments, LLC-PK1 cells lost viability when concomi-
tantly exposed to high concentrations of Tox A (100distinct from Tox A and Tox B (Fig. 3). The C3 toxin
is known to be relatively impermeable to intact cells and ng/mL) and cytochalasin D (1.0 mmol/L). At lower con-
centrations, Tox A (10 ng/mL) alone inhibited LLC-PK1thus requires relatively high concentrations [21]. The
need for a high concentration and limited supply of avail- 3H-thymidine uptake by 33.3 6 6.4%, while cytochalasin
D (0.1 mmol/L) was inhibited by 41.9 6 5.0% (N 5 4,able recombinant C3 confined these studies to the exami-
nation of the effects of C3 on 3H-thymidine uptake and both P , 0.01). Together, these concentrations of Tox
A and cytochalasin D produced a significant (P , 0.02)on apoptosis (Fig. 3). At 0.1 mg/mL, C3 did not affect
3H-thymidine uptake (22.3 6 13.6% vs. control, N 5 3, further inhibition of LLC-PK1 3H-thymidine uptake
(71.1 6 5.6%, N 5 4).NS). However, at 0.5 mg/mL, C3 significantly decreased
3H-thymidine uptake relative to control by 64.3 6 9.7% To confirm the annexin V binding results indicating
induction of apoptosis by Tox A and cytochalasin D,(N 5 3, P , 0.02). As can be seen in Figure 3, exposure
to C3 resulted in significant increases in not only annexin Brd UTP labeling in the absence and presence of Tox
A and cytochalasin D was done (Table 1). Both Tox AV binding, but also propidium iodide uptake.
We next examined the effects of LT82, an agent that and cytochalasin D induced dose-dependent effects to
increase Brd UTP labeling.modifies Ras, Rap, Ral, and Rac but not either Rho or
Cdc 42 in LLC-PK1 cells. LT82 at 10, 50, 100, 500, and To ascertain whether the effect of cytochalasin D in
inducing apoptosis could be due to its known effect to1000 ng/mL did not affect LLC-PK1 3H-thymidine incor-
poration (1103 6 192, 1066 6 203, 1088 6 208, 1042 6 disrupt the actin cytoskeleton, we examined the effects
of an agent that impairs cytoskeletal function by acting166 and 955 6 190 cpm/well, respectively) when com-
pared with control (979 6 176 cpm/well, N 5 six paired on the tubulin cytoskeleton (colchicine; Fig. 5). Colchi-
cine induced a very modest, but significant (P , 0.05)studies done in triplicate, P 5 NS). At 50, 100, and 500
ng/mL, LT82 also did not affect either 24-hour wound effect to increase LLC-PK1 apoptosis.
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Fig. 7. Effect of Clostridium difficile toxin A
and cytochalasin D (24 h) to affect LLC-PK1
expression of LLC-PK1 Bcl-xL. The bars repre-
sent the mean 6 SEM of five experiments and
depict the band area, as determined by densito-
metric analysis. Cytochalasin D modestly (P ,
0.05) decreases expression of Bcl-xL.
Effects of Tox A and Cytochalasin D on expression of Effect of pancaspase inhibitor on Tox A inhibition of
LLC-PK1 3H-thymidine uptakeBcl proteins
These studies were done to determine if Tox A (100 Since the pancaspase inhibitor prevented the effect of
ng/mL) and/or cytochalasin D (10 mmol/L) exert their Tox A to induce apoptosis, we examined the effect of
effects to induce apoptosis via changes in expression of the pancaspase inhibitor on Tox A inhibition of LLC-
proteins that can regulate the apoptotic process (Figs. 6 PK1 3H-thymidine uptake. In these paired studies (N 5
and 7). Initially, we examined the effects of Tox A and 3), Tox A at 10, 100, and 1000 ng/mL inhibited LLC-
cytochalasin D on LLC-PK1 cell Bcl-2 expression, as PK1 3H-thymidine uptake equivalently in the absence
determined by flow cytometry. In these paired studies, (228.8 6 4.8, 266.0 6 10.1, and 287.9 6 10.9%, respec-
the binding of antibodies directed against Bcl-2 did not tively) and presence (238.8 6 12.1, 264.4 6 14.3, and
differ from control in either Tox A (25.8 6 10.3% vs. 284.3 6 10.9%, respectively) of 100 mmol/L of the pan-
control, N 5 5, P 5 NS) or cytochalasin D-treated (6.7 6 caspase inhibitor. These results suggest that Tox A can
10.5% vs. control, N 5 5, P 5 NS) cells. Next, immu- inhibit LLC-PK1 3H-thymidine uptake independent of
noblotting was used to assess the effects of Tox A and stimulation of apoptosis.
cytochalasin D on expression of Bcl-x, BAX, BAD, and
Effect of Tox A, lethal toxin 82, and Cytochalasin DBAK proteins. We were unable to detect the presence
on Rhodamine phallotoxin stainingof BAX in LLC-PK1 lysates (data not shown). Neither
Tox A nor cytochalasin D appeared to affect expression These studies demonstrate that Tox A, lethal toxin
of either BAD (control intensity, 26,036 6 1591 pixels; 82, and especially cytochalasin D impair normal expres-
Tox, 27,250 6 1428 pixels; and cytochalasin D, 27,906 6 sion of the LLC-PK1 actin cytoskeleton (Fig. 9). With
1967 pixels, N 5 4, P 5 NS) or BAK (control intensity, Tox A and lethal toxin 82, a diminution in peripheral
28,648 6 2779 pixels; Tox A, 29,112 6 2662; and cytocha- staining and increased cytoplasmic staining occurred.
lasin D, 30,060 6 2,200 pixels; N 5 4, P 5 NS) in LLC- With cytochalasin D, an absence of peripheral staining
PK1 lysates. However, as can be seen in Figures 6 and 7, and marked intracytoplasmic staining in an aggregated
cytochalasin D but not Tox A significantly decreased the pattern were observed.
LLC-PK1 expression of Bcl-xL, an anti-apoptotic protein.
DISCUSSIONEffects of pancaspase inhibitor on Tox A- and
Cytochalasin D-induced LLC-PK1 apoptosis The results of the present studies support a role for
Rho protein involvement in several aspects of LLC-PK1In these studies, we examined the effects of boc-aspar-
cell function. Thus, two agents that inhibit Rho, Rac,tyl (OMe)-fluoromethyl ketone on Tox A and cytocha-
and Cdc 42 (Tox A and Tox B) significantly impair LLC-lasin D-promoted apoptosis (Fig. 8). At 100 mmol/L, the
PK1 3H-thymidine uptake and wound healing while stim-pancaspase inhibitor significantly (P , 0.05) attenuated
ulating apoptosis. Another bacterial toxin, C3, whichthe effect of both Tox A and cytochalasin D to promote
apoptosis. inhibits Rho (but not Rac and Cdc 42) by a different
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studies support a role for Rho as an important endoge-
nous cellular regulator of apoptosis.
We undertook studies to clarify the mechanism of
Rho protein regulation of apoptosis. While changes in
organization of cytoskeletal components occur in paral-
lel with the apoptotic process [24], there are limited data
as to whether disruption of the cytoskeleton can initiate
apoptosis [25]. Intact Rho protein function is well known
to be necessary for organization of the actin cytoskele-
ton. We found that cytochalasin D, another agent that
impairs organization of the actin cytoskeleton, also ex-
erts a concentration-dependent effect to stimulate LLC-
PK1 cell apoptosis. Timura et al and Demeester et al
also found an effect of cytochalasin D to induce apoptosis
in primary cultures of mouse proximal tubular cells and
in cultured porcine aortic endothelial cells, respectively
[4, 26]. Together, these and other observations [9, 27]
suggest that disruption of the actin cytoskeleton can in-
duce apoptosis in several cell types. It is thus possible
that Rho protein control of LLC-PK1 apoptosis occurs
via an effect to disrupt the actin cytoskeleton. Our re-
sults, however, clearly do not directly demonstrate that
Rho impairs LLC-PK1 function via an actin-dependent
mechanism. Rho is known to exert several cellular effects
independent of the actin cytoskeleton [1–3]. Moreover,
LT82 disrupted LLC-PK1 actin cytoskeleton but did not
mimic the effects of Tox A or B or C3. Also, Tox A and
cytochalasin D effects on LLC-PK1 3H-thymidine uptake
Fig. 8. Effect of a pancaspase inhibitor boc-aspartyl ([Ome]-fluoro- were additive. Together, these observations support an
methyl ketone) on Clostridium difficile toxin A-induced apoptosis (A) actin-independent effect of Rho. We also found a modest
and cytochalasin D-induced apoptosis (B) in LLC-PK1 cells. The bars effect of colchicine to induce LLC-PK1 apoptosis. Thisrepresent the mean 6 SEM of four experiments and depict the percent-
age of apoptotic cells as assessed by annexin V binding. Symbols in A observation suggests perhaps that not only disruption of
are: (j) control cells; ( ) toxin A-treated cells. Toxin A significantly the actin cytoskeleton, but also impairment of tubulin
(P , 0.01) induced apoptosis, and this apoptotic effect was abolished
components of the cytoskeleton can initiate LLC-PK1by a 100 mmol/L concentration of the pancaspase inhibitor. In B, the
bars represent the mean 6 SEM of five experiments and depict the apoptosis. The issue as to the mechanism(s) of effect
percentage of cells with annexin V binding. Symbols are: (j) control of Rho to regulate LLC-PK1 function clearly requirescells; ( ) cytochalasin D-treated cells. At 100 mmol/L, the pancaspase
further study.inhibitor significantly (P , 0.05) reduced the effect of cytochalasin D
zto induce apoptosis. Members of the Bcl-2 family of proteins exert signifi-
cant influences on the apoptotic process. These Bcl-2
proteins form homodimers and heterodimers, which ap-
pear to influence the apoptotic machinery by unknown
mechanism also stimulates LLC-PK1 apoptosis. A third mechanisms. Some members of this family (for example,
bacterial toxin, LT82, which can inhibit Ras, Rac, Ral, Bcl-2 and Bcl-xL) exert anti-apoptotic activity, while
and Rap, does not affect LLC-PK1 3H-thymidine incorpo- others (for example, BAD, BAX, and BAK) are pro-
ration, wound healing, or apoptosis. Collectively, these apoptotic. Since a bacterial toxin that activates Rho (cyto-
results support a role for Rho subfamily (Rho A, B, and toxic nercrotizing factor 1) was recently found to increase
C) regulation of several aspects of LLC-PK1 function. the expression of Bcl-2 and Bcl-xL, thereby retarding
Of special interest is our finding that inhibition of apoptosis in epithelial cells [28, 29], we examined the
Rho function induces LLC-PK1 apoptosis. We found that effects of Tox A and cytochalasin D on expression of
three Rho inhibitors significantly promote apoptosis, as some Bcl-2 proteins in LLC-PK1 cells. Neither Tox A or
assessed by two different techniques. In studies with cytochalasin D affected Bcl-2 BAD or BAK expression.
cultured intestinal cells, Tox B induced apoptosis [22], However, cytochalasin D but not Tox A significantly in-
and overexpression of C3 within chick embryo fibro- hibited expression of Bcl-xL, an anti-apoptotic protein.
blasts and rat aortic smooth muscle cells also stimulated While further studies are needed to ascertain whether
the modest decrease in Bcl-xL is of biologic significance,apoptosis [23]. Taken together, the present and previous
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Fig. 9. Effect of Clostridium difficile toxin A (100 ng/mL), lethal toxin 82 (1000 ng/mL), and cytochalasin D (10 mmol/L) on rhodamine phallotoxin
staining of LLC-PK1 cells. (A) Control. (B) Toxin A. (C) Lethal toxin. (D) Cytochalasin D-treated cells. Toxin A and lethal toxin result in diffuse
cytoplasmic redistribution, while cytochalasin D results in clumping of individual cells, diffuse cytoplasmic redistribution, and intracytoplasmic
aggregation.
these observations possibly suggest a mechanism whereby studied inhibited the effect of Tox A to induce apoptosis
but did not attenuate the effect of Tox A to inhibit 3H-cytochalasin D can promote apoptosis.
Our findings also support a role for Rho proteins in thymidine uptake. This observation supports that at least
some of the effects of Rho protein inhibition on LLC-the regulation of LLC-PK1 cell motility. This is perhaps
not surprising given the key role of the actin cytoskeleton PK1 mitogenesis and motility can occur independent of
the apoptotic process.in the formation of stress fibers and focal adhesion con-
nections. Indeed, an effect of Tox A, Tox B, and C3 to We should note some shortcomings of the present
studies. First, our results are based exclusively on theimpair intestinal epithelial cell motility has recently been
reported [21]. Moreover, microinjection of Rho and Rac use of selected bacterial toxins. Future studies that use
other approaches that result in gain or loss of Rho func-into Madin Darby canine kidney cells affects several
aspects of movement of these cells [30]. Together, the tion are clearly needed to confirm and extend our obser-
vations. Based on the experiments performed, we havepresent and previous observations provide strong evi-
dence that intact Rho function is necessary for the move- not established that the effects of Tox A, B, and C3 that
we observed are mediated via disruption of the actinment of several cell types.
One aspect of our studies that merits additional inves- cytoskeleton. Thus, the similarity of LLC-PK1 cell effects
induced by Rho inhibition and by cytochalasin D, whiletigation is the role of the apoptosis induced by inhibitors
of Rho in the observed inhibition of 3H-thymidine uptake compatible with such an interpretation, does not prove
a causal connection. Moreover, it is possible or evenand wound healing. The pancaspase inhibitor that we
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reductase inhibitors induce apoptosis in mouse proximal tubularlikely that Rho inhibition and cytochalasin D exert dif-
cells in primary culture. Kidney Int 52:962–972, 1997
ferential effects on this actin cytoskeleton. For example, 5. Vrtovsnik F, Couette S, Prie D, Lallemand D, Friedlander G:
the patterns of phalloidin staining produced by these Lovastatin-induced inhibition of renal epithelial cell proliferation
involves a P21ras activated, AP-1-dependent pathway. Kidney Intagents differed both quantitatively and qualitatively. In
52:1016–1027, 1997
addition, cytochalasin D—but not Tox A—decreased 6. Essig M, Vrtovsnik F, Nguyen G, Sraer JO, Friedlander G:
the expression of Bcl-xL. Although we found that three Lovastatin modulates in vivo and in vitro the plasminogen activa-
tor/plasmin system of rat proximal tubular cells: Role of geranyldistinct bacterial toxins that inhibit Rho by different
geranylation and Rho proteins. J Am Soc Nephrol 9:1377–1388,sites and mechanisms all induced apoptosis, we did not 1998
directly measure Rho function. Thus, we cannot be sure 7. Massy ZA, Guijarro C, O’Donnell MP, Kasiske BL, Keane
WF: Regulation of mesangial cell proliferating by the mevalonatethat test agents exerted comparable effects on Rho. The
pathway. Contrib Nephrol 120:191–196, 1997concentrations of Tox A and Tox B that we found to 8. Terada Y, Inoshita S, Nakashima O, Yamada T, Kuwahara M,
exert an effect of LLC-PK1 function differed signifi- Sasaki S, Marumo F: Lovastatin inhibits mesangial cell prolifera-
tion by p27kip1. J Am Soc Nephrol 9:2235–2243, 1991cantly. However, these toxins were obtained from differ-
9. Koch G, Benz C, Schmidt G, Olenik C, Aktories K: Role of Rhoent sources and were purified and assayed by different protein in lovastatin-induced breakdown of actin cytoskeleton.
techniques. Moreover, there are, to our knowledge, no J Pharmacol Exp Ther 283:901–909, 1997
10. Aktories K, Weller U, Chhatwal GS: Clostridium botulinumdata on the relative density of receptors for those toxins
type C produces a novel ADP-ribosyl transferase distinct fromon LLC-PK cells. Also, we did not do studies on polar- botulinum C2 toxin. FEBS Lett 212:109–113, 1987
ized cells grown on semipermeable substrates. One of the 11. Rubin EJ, Gill DM, Boquet P, Popoff MR: Functional modifica-
tion of a 21 kilodalton G protein when ADP ribosylated by co-toxins, C3, induced not only apoptosis but also necrosis, a
enzyme C3 of Clostridium botulinum. Mol Cell Biol 8:418–428,finding that differed from the effects of Tox A and B to 1988
promote apoptosis alone. Finally, in some cell types, 12. Sekine A, Fujiwara M, Narumiya S: Asparagine residue in the
Rho gene product is the modification site for botulinum ADP-there is a hierarchy with which Ras and Rho family
ribosyl transferase. J Biol Chem 264:8602–8605, 1998members interact. We have not explored this possible 13. Just I, Selzer J, Wilm M, von Eichel-Streiber C, Mann M,
interaction in our experiments. Aktories K: Glucosylation of Rho proteins by Clostridium difficile
toxin B. Nature 375:500–503, 1995In summary, the present studies demonstrate that inhi-
14. Just O, Wilm M, Selzer J, Rex G, von Eichel-Streiber C, Mannbition of Rho protein function inhibits LLC-PK1 3H- M, Aktories K: The enterotoxin from Clostridium difficile (Tox A)
thymidine uptake and wound healing while inducing monoglucosylates the Rho proteins. J Biol Chem 270:13932–13936,
1995apoptosis. Based on our results with Tox A, Tox B, and
15. Popoff MR, Chavez-Olarte E, Lemichez E, von Eichel-StreiberC3, these effects appear to be primarily attributable to
C, Thelestam M, Chardin P, Cussac D, Antonny B, Chavrier
inhibition of Rho A, B, and/or C. Comparable effects P, Flateur G, Giry M, de Gunzburg J, Boquet P: Ras, Rap and
Rac and small GTP-binding proteins are targets for Clostridiumare observed with cytochalasin D, another agent capable
sordelli lethal toxin glycosylation. J Biol Chem 271:10217–10224,of inhibiting the actin cytoskeleton. The effects of Tox A
1996
and cytochalasin D to induce apoptosis can be attenuated 16. El Hadj NB, Popoff MR, Marvaud JC, Payrastre B, Boquet P,
Geny B: G-protein-stimulated phospholipase D activity is inhibitedwith a pancaspase inhibitor. Together, our results pro-
by lethal toxin from Clostridium sordelli in HL-60 cells. J Biolvide evidence for a key role for Rho proteins in regula-
Chem 274:14021–14031, 1999
tion of several aspects of renal tubular epithelial cell 17. Popoff MR: Purification and characterization of Clostridium sorde-
lli lethal toxin and cross-reactivity with Clostridium difficile cyto-function including apoptosis. The results may have
toxin. Infect Immunol 55:35–43, 1987pathophysiologic implications in view of the fact that
18. Sponsel HT, Breckon R, Hammond W, Anderson RJ: Mecha-
apoptosis appears to be an important process in acute nisms of recovery from mechanical injury of renal tubular epithelial
and chronic renal failure [25, 31], and maintenance of cells. Am J Physiol 267:F257–F264, 1994
19. Anderson RJ, Ray C: Potential autocrine and paracrine mecha-the actin cytoskeleton is critically important for normal
nisms of recovery from mechanical injury of renal tubular epithelialcell polarity and function [32]. cells. Am J Physiol 274:F463–F472, 1998
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